-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Blood Drop: Malignant Hematology

Symposia: ASH-a-Palooza Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Education, Diseases, Treatment Considerations
Friday, December 6, 2024: 2:40 PM-2:50 PM
Station 1 (Gaslamp Quarter)
Friday, December 6, 2024: 3:00 PM-3:10 PM
Station 1 (Gaslamp Quarter)
Speaker:
John C. Byrd, MD, University of Cincinnati
Disclosures:
Byrd: Vincerx Pharma, Eilean Therapeutics, and Kurome Therapeutics: Current equity holder in private company; Abbvie, AstraZeneca, and Syndax: Consultancy.

The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.

John C. Byrd, MD

Department of Internal Medicine, University of Cincinnati, Cincinnati, OH